[go: up one dir, main page]

WO2001015777A8 - Pulmonary-administration of mineral ascorbates - Google Patents

Pulmonary-administration of mineral ascorbates

Info

Publication number
WO2001015777A8
WO2001015777A8 PCT/US1999/019977 US9919977W WO0115777A8 WO 2001015777 A8 WO2001015777 A8 WO 2001015777A8 US 9919977 W US9919977 W US 9919977W WO 0115777 A8 WO0115777 A8 WO 0115777A8
Authority
WO
WIPO (PCT)
Prior art keywords
pulmonary
administration
mineral ascorbates
ascorbates
mineral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/019977
Other languages
French (fr)
Other versions
WO2001015777A1 (en
Inventor
Jeffrey Zidichouski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxycal Laboratories Inc
Original Assignee
Oxycal Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxycal Laboratories Inc filed Critical Oxycal Laboratories Inc
Priority to AU57978/99A priority Critical patent/AU5797899A/en
Priority to PCT/US1999/019977 priority patent/WO2001015777A1/en
Publication of WO2001015777A1 publication Critical patent/WO2001015777A1/en
Publication of WO2001015777A8 publication Critical patent/WO2001015777A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Compositions and methods for pulmonary inhalation treatment. The composition includes a pharmaceutically acceptable mineral ascorbate and, optionally, one or more vitamin C metabolites.
PCT/US1999/019977 1999-08-31 1999-08-31 Pulmonary-administration of mineral ascorbates Ceased WO2001015777A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU57978/99A AU5797899A (en) 1999-08-31 1999-08-31 Pulmonary-adminstration of mineral ascorbates
PCT/US1999/019977 WO2001015777A1 (en) 1999-08-31 1999-08-31 Pulmonary-administration of mineral ascorbates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/019977 WO2001015777A1 (en) 1999-08-31 1999-08-31 Pulmonary-administration of mineral ascorbates

Publications (2)

Publication Number Publication Date
WO2001015777A1 WO2001015777A1 (en) 2001-03-08
WO2001015777A8 true WO2001015777A8 (en) 2001-10-11

Family

ID=22273502

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/019977 Ceased WO2001015777A1 (en) 1999-08-31 1999-08-31 Pulmonary-administration of mineral ascorbates

Country Status (2)

Country Link
AU (1) AU5797899A (en)
WO (1) WO2001015777A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718694B2 (en) * 1997-10-16 2010-05-18 Children's Hospital & Research Center At Oakland Compositions and methods for therapy for diseases characterized by defective chloride transport
WO2004080427A2 (en) * 2003-03-12 2004-09-23 Schneider Daniel J Method of preventing and treating infections that attack mucosa and assisting rehabilitation thereafter using topically applied ascorbic acid
JP4671092B2 (en) * 2003-11-20 2011-04-13 森重 文江 Virus infection prevention and countermeasures
WO2005123064A1 (en) * 2004-06-10 2005-12-29 Board Of Trustees Of Michigan State University Adrenergic complement inhaler comprising compounds such as ascorbates tocopherols or polycaboxylic acid chelators
GB2525626A (en) * 2014-04-29 2015-11-04 Alexander Francois Robert Templet Composition and method for inhalable nutritional element

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU1819138C (en) * 1987-07-15 1993-05-30 Юрий Викторович Востриков Method of treatment of nonspecific bronchopneumonia in calves
US5944012A (en) * 1996-03-25 1999-08-31 Pera; Ivo E. Method for dispensing antioxidant vitamins by inhalation background of the invention

Also Published As

Publication number Publication date
WO2001015777A1 (en) 2001-03-08
AU5797899A (en) 2001-03-26

Similar Documents

Publication Publication Date Title
ZA200206905B (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same.
EP1072254A4 (en) Food compositions, compositions for oral cavity and medicinal compositions for preventing or treating periodontosis and method for preventing or treating periodontosis
AU2001228759A1 (en) Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols
AU2003233010A1 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
AU2003246810A1 (en) Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives
AU1392900A (en) 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses
GB9903216D0 (en) Preservative compounds,compositions and methods of making and using the same
WO2000066104A3 (en) Ace-2 inhibiting compounds and methods of use thereof
AU2001284413A1 (en) Medicinal compositions for preventing or treating heart failure
AU2002356533A1 (en) Methods using 1, 2-dithiol-3-thiones and their derivatives and metabolites for inhibiting angiogenesis
AU2001284149A1 (en) Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
ZA200110150B (en) Streptogramin derivatives, preparation and compositions containing them.
AU4996100A (en) (s,r) formoterol methods and compositions
WO2000050062A3 (en) Methods and compositions for altering mucus secretion
IL157065A0 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
AU2002215333A1 (en) Compositions for release of radiosensitizers, and methods of making and using the same
AU2002368133A1 (en) 1,3-azole derivative and medicinal composition containing the derivative for treatment for thombosis
WO2001015777A8 (en) Pulmonary-administration of mineral ascorbates
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
AU5368699A (en) Derivatives of triptolide, and preparation and uses thereof
AU2001270310A1 (en) Compositions for sustained release of antineoplastic taxanes, and methods of making and using the same
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
PL366629A1 (en) 3,7-diazabicyclo [3.3.1] formulations as anti-arrythmic compounds
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA CN IS JP KP MX NO NZ SG TR US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C1

Designated state(s): AU CA CN IS JP KP KR MX NO NZ SG TR US

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 10/2001 UNDER (81) ADD "KR"; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

122 Ep: pct application non-entry in european phase